However, only the study by Nadjar et al. (2012), performed on a large ALS population (694 patients), thus presenting higher statistical power (Veyrat-Durebex et al., 2014), showed a significant decrease in serum transferrin levels in ALS subjects. The gene discussed is TF; the disease is amyotrophic lateral sclerosis.